Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK MHRA asks physicians to prescribe licensed melatonin products

This article was originally published in Scrip

Executive Summary

The UK MHRAis urging doctors and pharmacists to prescribe and supply only licensed melatonin, now that Lundbeck's modified-release product Circadin 2mg tablets are available in the UK. Before June, melatonin was only available in the UK as an unlicensed product. Many of these were non-pharmaceutical grade (non-GMP) products imported from the US, where they are classed as supplements, the MHRA points out. However, the agency recognises that there may be individuals for whom the licensed product does not meet their clinical needs, such as when alternative dosage forms are required, and licensed melatonin products can still be imported when prescribers give written details of the special clinical need to the importer, which submits this to the MRHA. Melatonin products have previously been the largest category of unlicensed products imported into the UK; the agency received 1,053 notifications of imports of these products in the six months to June.

The UK MHRAis urging doctors and pharmacists to prescribe and supply only licensed melatonin, now that Lundbeck's modified-release product Circadin 2mg tablets are available in the UK. Before June, melatonin was only available in the UK as an unlicensed product. Many of these were non-pharmaceutical grade (non-GMP) products imported from the US, where they are classed as supplements, the MHRA points out. However, the agency recognises that there may be individuals for whom the licensed product does not meet their clinical needs, such as when alternative dosage forms are required, and licensed melatonin products can still be imported when prescribers give written details of the special clinical need to the importer, which submits this to the MRHA. Melatonin products have previously been the largest category of unlicensed products imported into the UK; the agency received 1,053 notifications of imports of these products in the six months to June.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC031595

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel